Host Julia Cartwright explores where semaglutide fits in endocrinologists' type 2 diabetes treatment strategies. When metformin stops working, semaglutide increasingly replaces insulin as the next step, offering glucose-dependent blood sugar control, weight loss, and cardiovascular protection without hypoglycemia risk. Drawing on clinical trials involving over 8,400 patients, Julia examines mechanisms, benefits, thyroid safety considerations, and guideline recommendations shaping modern diabetes care.
Loved this episode? Discover more original shows from the Quiet Please Network at QuietPlease.ai, explore our curated favorites here amzn.to/42YoQGI, and catch just a slice of our AI hosts in action on Instagram at instagram.com/claredelish and YouTube at youtube.com/@DIYHOMEGARDENTV
This content was created in partnership and with the help of Artificial Intelligence AI
This episode includes AI-generated content.
続きを読む
一部表示